22-45693008-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_013236.4(ATXN10):c.321G>A(p.Thr107=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00338 in 1,613,974 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 17 hom. )
Consequence
ATXN10
NM_013236.4 synonymous
NM_013236.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.66
Genes affected
ATXN10 (HGNC:10549): (ataxin 10) This gene encodes a protein that may function in neuron survival, neuron differentiation, and neuritogenesis. These roles may be carried out via activation of the mitogen-activated protein kinase cascade. Expansion of an ATTCT repeat from 9-32 copies to 800-4500 copies in an intronic region of this locus has been associated with spinocerebellar ataxia, type 10. Alternatively spliced transcript variants have been described.[provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 22-45693008-G-A is Benign according to our data. Variant chr22-45693008-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 196455.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.66 with no splicing effect.
BS2
High AC in GnomAd4 at 338 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATXN10 | NM_013236.4 | c.321G>A | p.Thr107= | synonymous_variant | 3/12 | ENST00000252934.10 | NP_037368.1 | |
ATXN10 | NM_001167621.2 | c.129G>A | p.Thr43= | synonymous_variant | 2/11 | NP_001161093.1 | ||
ATXN10 | XM_047441314.1 | c.321G>A | p.Thr107= | synonymous_variant | 3/12 | XP_047297270.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATXN10 | ENST00000252934.10 | c.321G>A | p.Thr107= | synonymous_variant | 3/12 | 1 | NM_013236.4 | ENSP00000252934 | P1 | |
ATXN10 | ENST00000381061.8 | c.129G>A | p.Thr43= | synonymous_variant | 2/11 | 2 | ENSP00000370449 | |||
ATXN10 | ENST00000470722.1 | n.280G>A | non_coding_transcript_exon_variant | 3/4 | 3 | |||||
ATXN10 | ENST00000498009.5 | n.495G>A | non_coding_transcript_exon_variant | 3/6 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00222 AC: 338AN: 152164Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
338
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00240 AC: 604AN: 251422Hom.: 1 AF XY: 0.00247 AC XY: 335AN XY: 135890
GnomAD3 exomes
AF:
AC:
604
AN:
251422
Hom.:
AF XY:
AC XY:
335
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00350 AC: 5116AN: 1461692Hom.: 17 Cov.: 31 AF XY: 0.00347 AC XY: 2521AN XY: 727130
GnomAD4 exome
AF:
AC:
5116
AN:
1461692
Hom.:
Cov.:
31
AF XY:
AC XY:
2521
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00222 AC: 338AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.00212 AC XY: 158AN XY: 74462
GnomAD4 genome
AF:
AC:
338
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
158
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | ATXN10: BP4, BP7 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2015 | - - |
Spinocerebellar ataxia type 10 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 25, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at